Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon Nov 12, 2021 2:19pm
88 Views
Post# 34120867

Anyone know if "InfoMed fixes clocks too"? ; - )

Anyone know if "InfoMed fixes clocks too"? ; - )

Afterall...they are Swiss

AP - "Tom was right" , even a busted clock is right 2X/day

Thanks AP!

OH...one more thing ( Peter Falk )...Alter-cyte was "founded" in 2012 NOT 2021 ; - )

"To be clear" ( throat clear - NO it's not CV19 )

The brakes aren't the only thing being "pumped"

The phase 3 Euphrates Trial ended ~ 65 months ago ( ~ 5 & 1/2 years ) It was HEAVILY advertised as a FAILURE ( that is with a BOLD F ).  The data from the FAILURE is now magically being used to populate a minimum of 40% ( almost 1/2 ) the data in the Open label phase 3B US confirmatory TIGRIS trial.  The completely safe medical device ( unless used in France, "apparently" ) is guided by a fully FDA approved ( 2003 ) companion diagnostic ( the EAA ) and the filter is administered by a fully FDA approved ( 2018 ) mobile dialysis unit the SAMI.  We have achieved 6 patients across over 10 recruiting hospitals over an ~ 4 month period.  The product we are attempting to approve has been used on over 300,000 patients and is approved globally and carries a US "extended use" ( AKA compassionate care ) approval ( June 2016 ).

Bear in mind the trial is allowing a 2 to 1 ratio of PMX ( proposed treatment ) usage in a critical care ( life and death setting ) where the most diificult of endpoints ( 28 day mortality ) is set as the primary endpoint.

We've been left in the dark ( not just buy the consistent dark pool trading ) but also by a complete lack of  data or commentary on the Coivd19 trial and also by the actual efficacy of the Open label TIGRIS trial.  "They" know EXACTLY what the efficacy is after 25 patients, time to share trusted fiduciary types.  We await the activity of today and of course look forward to Paradigm's SP target on the back of 6 patients enrolled over 4 months ; - )

OH I do smell a winner here.....what might the next chapter bring to those on the inside?

To borrow a line from an important video "I , I , I , I , I , I " ( i counted 5 "eyes" ) was wrong and you were right....given this new "Delta" issue...what might we being doing with our "extended use" approval for PMX and FULL FDA approval for PMX as it pertains to Covid19?

Please do realize that after ONE year as "acting" IR in the US, our rep here managed to garmer one 10K trade on the day "he -( former MJAR pot exec)" presented at Benzinga..it was 100% SHORT ; - )

AS mentioned at the top..."the brakes aren't the only thing being PUMPED"  disgusting!

<< Previous
Bullboard Posts
Next >>